New Delhi: In a major setback for India’s fight against the COVID pandemic, the World Health Organization (WHO) has not given its full approval to India’s homemade Covaxin for emergency use.
Concerning this, the WHO stated on Tuesday that a final examination is required in order to give the vaccine its final approval for emergency use. Therefore, it has sought some “additional clarification” from its makers Bharat Biotech.
In an official report WHO stated that "The Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid 19 vaccine can be listed for emergency use under the EUL procedure".
Also Read: 103 year old man successfully defeats COVID-19 in Mizoram
"The TAG met today (October 26, 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine," the WHO added.
The health agency has also said that it expects to receive the required information by the end of this week.
Covaxin, which is India’s first homemade COVID vaccine proved to be 77.8 per cent effective during its Phrase 3 clinical trials. However, earlier in the past week WHO stated that it wanted one more “additional piece” of information from its makers in order to ensure that vaccine is safe for everyone.
Continue Reading
